ALS-linked loss of Cyclin-F function affects HSP90

Abstract

The founding member of the F-box protein family, Cyclin-F, serves as a substrate adaptor for the E3 ligase Skp1-Cul1-F-box (SCF)Cyclin-Fwhich is responsible for ubiquitination of proteins involved in cell cycle progression, DNA damage and mitotic fidelity. Missense mutations inCCNFencoding for Cyclin-F are associated with amyotrophic lateral sclerosis (ALS). However, it remains elusive whetherCCNFmutations affect the substrate adaptor function of Cyclin-F and whether altered SCFCyclin-F–mediated ubiquitination contributes to pathogenesis inCCNFmutation carriers. To address these questions, we set out to identify new SCFCyclin-Ftargets in neuronal and ALS patient–derived cells. Mass spectrometry–based ubiquitinome profiling ofCCNFknockout and mutant cell lines as well as Cyclin-F proximity and interaction proteomics converged on the HSP90 chaperone machinery as new substrate candidate. Biochemical analyses provided evidence for a Cyclin-F–dependent association and ubiquitination of HSP90AB1 and implied a regulatory role that could affect the binding of a number of HSP90 clients and co-factors. Together, our results point to a possible Cyclin-F loss-of-function–mediated chaperone dysregulation that might be relevant for ALS.